Difficulties arising in reimbursement recommendations on new medicines due to inadequate reporting of population adjustment indirect comparison methods

Eileen M. Holmes, Joy Leahy, Cathal D. Walsh, Arthur White, Peter T. Donnan, Felicity Lamrock

Research output: Contribution to journalArticlepeer-review

Abstract

Indirect treatment comparisons are useful to estimate relative treatment effects when head-to-head studies are not conducted. Statisticians at the National Centre for Pharmacoeconomics Ireland (NCPE) and Scottish Medicines Consortium (SMC) assess the clinical and cost-effectiveness of new medicines as part of multidisciplinary teams. We describe some shared observations on areas where reporting of population-adjustment indirect comparison methods is causing uncertainty in our recommendations to decision-making committees when assessing reimbursement of medicines.

Original languageEnglish
Pages (from-to)615-617
Number of pages3
JournalResearch Synthesis Methods
Volume10
Issue number4
DOIs
Publication statusPublished - 1 Dec 2019

Keywords

  • decision making
  • evidence synthesis
  • population-adjusted indirect comparisons
  • statistical models

Fingerprint

Dive into the research topics of 'Difficulties arising in reimbursement recommendations on new medicines due to inadequate reporting of population adjustment indirect comparison methods'. Together they form a unique fingerprint.

Cite this